These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 11344889)

  • 1. Laws prohibiting over-the-counter syringe sales to injection drug users: relations to population density, HIV prevalence, and HIV incidence.
    Friedman SR; Perlis T; Des Jarlais DC
    Am J Public Health; 2001 May; 91(5):791-3. PubMed ID: 11344889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Over-the-counter but out of reach: a pharmacy-based survey of OTC syringe sales in Tijuana, Mexico.
    Pollini RA; Gallardo M; Ruiz S; Case P; Zaller N; Lozada R
    J Health Care Poor Underserved; 2014 May; 25(2):637-51. PubMed ID: 24858873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Demographic, risk, and spatial factors associated with over-the-counter syringe purchase among injection drug users.
    Stopka TJ; Lutnick A; Wenger LD; Deriemer K; Geraghty EM; Kral AH
    Am J Epidemiol; 2012 Jul; 176(1):14-23. PubMed ID: 22562660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonprescription syringe sales: a missed opportunity for HIV prevention in California.
    Pollini RA; Rudolph AE; Case P
    J Am Pharm Assoc (2003); 2015; 55(1):31-40. PubMed ID: 25575149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New York City pharmacists' attitudes toward sale of needles/syringes to injection drug users before implementation of law expanding syringe access.
    Coffin PO; Linas BP; Factor SH; Vlahov D
    J Urban Health; 2000 Dec; 77(4):781-93. PubMed ID: 11194317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Public health interventionists, penny capitalists, or sources of risk?: assessing street syringe sellers in Hartford, Connecticut.
    Stopka TJ; Singer M; Santelices C; Eiserman J
    Subst Use Misuse; 2003 Jul; 38(9):1345-77. PubMed ID: 12908815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV among injection drug users in large US metropolitan areas, 1998.
    Friedman SR; Lieb S; Tempalski B; Cooper H; Keem M; Friedman R; Flom PL
    J Urban Health; 2005 Sep; 82(3):434-45. PubMed ID: 16014877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High street prices of syringes correlate with strict syringe possession laws.
    Rich JD; Foisie CK; Towe CW; McKenzie M; Salas CM
    Am J Drug Alcohol Abuse; 2000 Aug; 26(3):481-7. PubMed ID: 10976670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Self-reported participation in voluntary nonprescription syringe sales in California's Central Valley.
    Pollini RA
    J Am Pharm Assoc (2003); 2017; 57(6):677-685. PubMed ID: 28807658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temporal trends in spatial access to pharmacies that sell over-the-counter syringes in New York City health districts: relationship to local racial/ethnic composition and need.
    Cooper HL; Bossak BH; Tempalski B; Friedman SR; Des Jarlais DC
    J Urban Health; 2009 Nov; 86(6):929-45. PubMed ID: 19911283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is crime associated with over-the-counter pharmacy syringe sales? Findings from Los Angeles, California.
    Stopka TJ; Geraghty EM; Azari R; Gold EB; DeRiemer K
    Int J Drug Policy; 2014 Mar; 25(2):244-50. PubMed ID: 24495711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of increased legal access to needles and syringes on community pharmacies' needle and syringe sales--Connecticut, 1992-1993.
    Valleroy LA; Weinstein B; Jones TS; Groseclose SL; Rolfs RT; Kassler WJ
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Sep; 10(1):73-81. PubMed ID: 7648288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An analysis of ethical issues in prescribing and dispensing syringes to injection drug users.
    Lazzarini Z
    Health Matrix Clevel; 2001; 11(1):85-128. PubMed ID: 11345679
    [No Abstract]   [Full Text] [Related]  

  • 14. Impact of increased legal access to needles and syringes on practices of injecting-drug users and police officers--Connecticut, 1992-1993.
    Groseclose SL; Weinstein B; Jones TS; Valleroy LA; Fehrs LJ; Kassler WJ
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Sep; 10(1):82-9. PubMed ID: 7648290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New York State pharmacists' attitudes toward needle and syringe sales to injection drug users before implementation of syringe deregulation.
    Linas BP; Coffin PO; Backes G; Vlahov D
    J Urban Health; 2000 Dec; 77(4):768-80. PubMed ID: 11194316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacy access to syringes among injecting drug users: follow-up findings from Hartford, Connecticut.
    Singer M; Baer HA; Scott G; Horowitz S; Weinstein B
    Public Health Rep; 1998 Jun; 113 Suppl 1(Suppl 1):81-9. PubMed ID: 9722813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deregulation of the sale and possession of syringes for HIV prevention among injection drug users.
    Vlahov D
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Sep; 10(1):71-2. PubMed ID: 7648287
    [No Abstract]   [Full Text] [Related]  

  • 18. The estimated prevalence and incidence of HIV in 96 large US metropolitan areas.
    Holmberg SD
    Am J Public Health; 1996 May; 86(5):642-54. PubMed ID: 8629714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Syringe access for injection drug users in Rhode Island.
    Boutwell A; Rich JD
    Med Health R I; 2004 Jan; 87(1):15-6. PubMed ID: 14989076
    [No Abstract]   [Full Text] [Related]  

  • 20. Syringe prescription to prevent HIV infection in Rhode Island: a case study.
    Rich JD; Macalino GE; McKenzie M; Taylor LE; Burris S
    Am J Public Health; 2001 May; 91(5):699-700. PubMed ID: 11344871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.